NLS Pharmaceutics Ltd. Quarterly Common Stock, Par or Stated Value Per Share in USD/shares from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: CHF/shares and USD/shares
Description: Face amount or stated value per share of common stock.
Summary: NLS Pharmaceutics Ltd. quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2020 to Q2 2023.
NLS Pharmaceutics Ltd. Common Stock, Par or Stated Value Per Share for the quarter ending June 30, 2023 was 0.02 USD/shares, unchanged year-over-year.

Common Stock, Par or Stated Value Per Share, Quarterly (USD/shares)

Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$0.02	$0	0%	Jun 30, 2023	6-K	2023-12-06
Q4 2022	$0.02	$0	0%	Dec 31, 2022	6-K	2023-12-06
Q2 2022	$0.02			Jun 30, 2022	6-K	2022-10-11
Q4 2021	$0.02	$0	0%	Dec 31, 2021	6-K	2022-10-11
Q4 2020	$0.02			Dec 31, 2020	20-F	2022-03-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.